Select
PSMA
Personalized Treatment Predictions
SelectPSMA analyzes PSMA-PET/CT scans to help physicians identify which patients are most likely to benefit from treatment.
By providing insight into tumor characteristics, SelectPSMA enables more personalized evidence-based decisions, improving outcomes while avoiding unnecessary toxicities.
How
SelectPSMA Works
SelectPSMA analyzes whole-body tumor characteristics to predict response to PSMA-targeted radioligand therapy, empowering clinicians with greater confidence in patient selection, reducing ineffective treatments, and driving more personalized prostate cancer care.
PSMA-PET/CT Image Upload
1
Upload PSMA-PET/CT imaging data securely to Nucs Al's platform, ensuring privacy and confidentiality.
Tumor Detection Al-Technology
2
Clinically validated imaging biomarkers derived from PSMA-PET/CT, including whole-body tumor burden, are analyzed to predict likelihood of response to PSMA-targeted therapy.
Physician Assessment
3
Physicians review and validate findings directly within the interface, with the ability to make edits before generating a structured, shareable report.
SelectPSMA Analysis
4
The AI classifies the scan as biomarker-positive or biomarker-negative, generating a clear, intuitive report to aid clinical decision-making.
Report Generation
5
The result: more confident patient selection, fewer futile treatments, and improved personalization in advanced prostate cancer care.
Key Features
SelectSMA supports advanced clinical and research decision-making by identifying which patients are most likely to benefit from PSMA-targeted therapies. From therapy planning to trial enrollment, SelectSMA brings predictive precision to every step of the treatment pathway — helping clinicians personalize care with confidence.
Patient Selection
Identifies patients unlikely to benefit from treatment with PSMA targeted therapy.
Precision Medicine
Improves patient outcome while minimizing the occurrence of treatment-related side effects.
Evidence-Based Decisions
Assists physicians in clinical decision-making process with robust data.
Audience Value Overview
SelectPSMA delivers measurable value to every stakeholder
SelectPSMA improves selection and decision-making across the prostate cancer care ecosystem. Whether you're reading scans, designing trials, or investing in next-gen technology, SelectPSMA brings tangible impact.
Clinical Applications
SelectPSMA supports clinical decision-making by identifying patients most likely to benefit from PSMA-targeted therapies. From therapy planning to trial enrollment, SelectPSMA adds precision at every stage, helping clinicians personalize care with confidence.
Treatment Planning
Support personalized therapy strategies by providing predictive insights based on PSMA imaging data.
Trial Enrollment
Standardize eligibility criteria and enrich clinical trial cohorts using imaging-based selection parameters.
Patient Selection
Identify patients unlikely to benefit from PSMA-targeted therapies with high confidence.
Treatment Selection
Focus on the right patient for the right treatment by identifying likely non-responders to RLT before it begins.
MDT Support
Intuitive, sharable reports for tumor boards and patient consultations.
Radiomics / Research
Export structured data in a CSV to support biomarker discovery, response modeling, and radiomics.
negative predictive value for identifying non-responders
higher risk of progression for non-responders vs responders
higher risk of death for non-responders vs responders
Accuracy in PSMA-positive lesion detection
Accuracy in TNM staging
Accuracy in whole-body tumor quantification
Frequently asked questions
The tool aids in selecting candidates for PSMA-RLT by accurately identifying those with a low probability of treatment response.
PSMA-PET/CT scans.
SelectPSMA operates on a cloud-based server, the report exports into a PDF.
SelectPSMA is not yet CE marked or FDA cleared, but both are in progress.
To request access to SelectPSMA for investigational use, please get in touch with us through the 'Contact Us' button above.
The Nucs AI platform features an intuitive interface, complemented by comprehensive training, dedicated support, and reliable troubleshooting to ensure seamless integration into your workflow.